Study suggests AstraZeneca vaccine is effective against Brazil COVID-19 variant

Reading Time: < 1 minute

Preliminary studies suggest the AstraZeneca vaccine will protect against the P1 variant of the coronavirus, Mauricio Zuma, the head of production at Brazil’s Fiocruz biomedical institute said on Monday, confirming a Reuters report on Friday.

The Brazil variant is worrying experts because it is highly contagious and has led several countries to ban travel from the Latin American nation.

via Reuters

Once you're here...

Discover more from CDE News - The Dispatch

Subscribe now to keep reading and get access to the full archive.

Continue reading